<DOC>
	<DOCNO>NCT01988740</DOCNO>
	<brief_summary>The find ischemia-modified albumin ( IMA ) increase pre-eclamptic pregnancy suggest role IMA potential biomarker abnormal placental development relate miscarriage.This study undertaken evaluate IMA level woman recurrent pregnancy loss ( RPL ) .</brief_summary>
	<brief_title>Markers Oxidative Stress Early Week Miscarriage : Ischemia Modified Albumin</brief_title>
	<detailed_description>Ischemia-modified albumin ( IMA ) measure albumin cobalt bind test relatively new biomarker identification myocardial ischemia . Experimental study show pregnancy normally develop relatively hypoxic intrauterine environment , subsequent reperfusion oxidative stress important physiological trophoblast development . The finding maternal serum IMA level raise early pregnancy provide support IMA potential marker abnormal placental development may relate early pregnancy loss . In study , aim evaluate maternal circulate IMA level woman RPL compare healthy control .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<criteria>first trim pregnancy absence fetal cardiac activity absence fetal pole history two unexplained first trim miscarriage live birth apparently healthy woman attend antenatal care first trimester least one previous uneventful natural pregnancy preexist diabetes vascular disease exclude diagnosis chromosomal , anatomic , endocrinologic autoimmunologic etiology recurrent pregnancy loss Women multiple pregnancy major minor fetal anomaly current smoker</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Ischemia-modified albumin</keyword>
	<keyword>Recurrent pregnancy loss</keyword>
	<keyword>Abnormal placenta</keyword>
</DOC>